Following Up For Better Health: Improving Non-Communicable Disease Compliance in Urban India

How to cite

Schaner, Simone; Bennett, Daniel. 2015. "Following Up For Better Health: Improving Non-Communicable Disease Compliance in Urban India." AEA RCT Registry. AEARCTR-0000812. https://doi.org/10.1257/rct.812-2.0

Download: BibTeX · RIS — for reference managers without a browser translator. Zotero and most others pick up this page's citation metadata directly.

Simone Schaner* , Daniel Bennett

* Primary investigator

Registry ID
AEARCTR-0000812
DOI
https://doi.org/10.1257/rct.812-2.0
First registered
Last updated
Status
Completed
Trial dates
2015-11-16 – 2017-10-01
Countries
India (Mumbai)
JEL codes
I12, D83, D03
Registry record
http://www.socialscienceregistry.org/trials/812

Abstract

The majority of individuals with non-communicable diseases (NCDs) live in the developing world, where prevalence rates are growing rapidly as nations become richer and more urban. In cities, where most individuals have access to a variety of medical providers, improving adherence to treatment is key to reducing morbidity from NCDs. We will partner with Swasth India, which operates private health clinics in the slums of Mumbai, to evaluate experimentally several interventions designed to improve NCD adherence. These interventions include (a) SMS reminders to adhere to treatment, (b) patient education on NCDs and the consequences of non-adherence, (c) a discount for NCD follow-up visits and medicine, and (d) a “regular patient” lottery, where the number of follow-up visits increases the value of the lottery prize.

Intervention

All of the interventions in this study aim to improve compliance with treatment regimens for diabetes and hypertension. The first set of interventions will provide patients with information about the implications and proper treatment of these diseases. We will frame the information in either positive or negative terms by emphasizing either the gains from compliance or the losses from non-compliance. The second intervention is an SMS-based reminder service. We will elicit the willingness to pay for reminders and then compare the willingness to pay with the compliance benefit of reminders. Finally, we will offer price discounts for medical care, including both certain and lottery-based discounts.

Experimental design

All study participants will be randomly assigned to either the control group or a treatment group, which will receive a combination of the interventions described below.
(1) Gain and Loss-Framed Health Information. We will train a team of community health workers (CHWs) to counsel patients for diabetes and hypertension. The information session, will explain (a) what the condition is, (b) the long-term consequences of failure to manage the condition, including severe morbidity and mortality and (c) the impact of disease management on the prognosis of the disease. Individuals will be randomly assigned either to information framed in gain/positive terms (e.g. “if you comply with recommended treatment you will support your long-run health and avoid negative health complications”) or information framed in loss/negative terms (e.g. “if you do not comply with recommended treatment you will damage your long-run health and may experience negative health complications”) or will receive no information.
(2) First and Second Stage Reminders: Individuals randomly selected for this treatment will all receive SMS reminders on a weekly or bi-weekly basis and will remind patients to take their medication and to follow-up with the doctor at the recommended interval. After three months, conditional on their willingness to pay for reminders for the rest of the year (measured using a BDM procedure), some of the individuals in this group will continue getting reminders for the rest of the year. These form the group that receives second stage reminders. The individuals who received reminders only for the first three months, will form the group that receives first stage reminders. There will also be a group that receives no reminders
(3) Pricing: Individuals will be randomly assigned to receive a 25% discount on visits to a Swasth clinic, or entry into a lottery that produces the same expected value of discount as does the sure discount, or will not receive any price incentives

Design details

Randomization method
Using a computer randomization tool, randomization will be done on unique IDs assigned to each patient.
Randomization unit
The randomization will be conducted at the individual level, and will be stratified by disease type and whether the participant is a pre-existing Swasth patient.
Clusters
3498 individuals
Observations
3498 individuals
Arms
There will be 1166 people enrolled in each of the pricing arms (no discount, fixed discount, lottery discount). Same goes for the three information arms (no info, positively framed info, negatively framed info). 80% of the full sample (2798) will be enrolled in stage 1 reminders and 1399 people will be enrolled in stage 2 reminders.
Primary outcomes
Using a baseline survey, an intermediate follow-up survey, and a final follow-up survey, we will measure/obtain: 1. Biometric outcomes, including blood sugar, blood pressure, weight, and height. 2. Self-reported doctors’ visits, diet, and use of medication 3. Self-reported morbidities related to diabetes and hypertension, such as pain, dizziness, and lethargy, as well as secondary outcomes such as labor supply and self-reported well-being. 4. The consumption of foods that may be problematic for at-risk people. 4. Knowledge and beliefs about the NCDs 5. Willingness-to-pay for reminders for patients 6. The utilization of clinic consultations.

Cited by

No citation data available for this registration yet.

Keywords